Understand, predict, engineer
Ben Lehner joins the Sanger Institute as a new Senior Group Leader. He seeks to lay the foundations for programmable biology.
From genomes to medicines: an interview with Ian Dunham
Ian Dunham has been a pillar of Open Targets since its inception. Helena Cornu sat down with him to understand how his career led him from the Human Genome Project to Director of Open Targets, and what he envisions for the future of the consortium.‌
The evolutionary history of humans
Mohamed Almarri has recently completed a PhD studying population history and global genetic diversity.
Perfume, jazz and immunogenetics
Dr Velislava Petrova is a Postdoctoral Fellow working in immunogenetics in Dr Carl Anderson’s group at the Sanger Institute. Currently she is working at the United Nations Programme on HIV/AIDS (UNAIDS) Office of Innovation in Geneva
25 years of pushing the scientific boundaries
From one human genome to hundreds of thousands, to every single cell in the body, to the genome of every species on the planet – DNA sequencing is accelerating. On our 25th anniversary we look at the evolution, application and potential of this powerful science.
